Status:
UNKNOWN
INvestigating DIGital Outcomes in the Community
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
Imperial College Healthcare NHS Trust
Conditions:
Cancer
Eligibility:
All Genders
16+ years
Brief Summary
To explore the feasibility and best methodology for collecting patient-reported outcome measures in patients who have previously been treated for cancer and are living in the community. The investiga...
Detailed Description
INDIGO Community aims to both collect data on patient-reported outcome measures (PROMS) and patient-reported experience measures (PREMS) and data on the impact of how to do this. The focus is on adul...
Eligibility Criteria
Inclusion
- Anyone over the age of 16 who has been diagnosed (receiving treatment is not an inclusion criteria although the investigators expect as this is a long-term survivorship study all participants will have received treatment) for any type of cancer in the past (\> 12 months) can participate.
- Participants who self-identify as having previously (time unlimited) received a diagnosis of cancer, based on histological, radiological, or clinical grounds (primary and/or metastatic cancer). Current treatment is not a barrier to participation, but the emphasis is on patients who have completed treatment.
- Participants need to be able to access the secure online platform, using a mobile device or computer.
- Have capacity and be able to provide informed consent via the online platform.
- To be able to understand, read and write English, with or without support from a trusted individual e.g., friends, family, carer.
Exclusion
- Participants recently diagnosed with cancer (less than 12 months ago).
- Participants unable to access secure online platform.
- Participants who do not have sufficiently good understanding of written English to complete the PROMs and are unable to be supported by a trusted individual to complete the questionnaire.
- Participants lacking capacity and unable to give informed consent.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT06095024
Start Date
December 1 2023
End Date
June 1 2025
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Healthcare NHS Trust
London, United Kingdom, W6 8RF